Idelvion approved for hemophilia B

HealthDay News Idelvion has been approved by the U.S. Food and Drug Administration to replace a deficient blood clotting factor among people with hemophilia B.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news